HS Code 30024129 โ Vaccines for human medicine (COVID-19 etc.)
Chapter 30 (Pharmaceutical Products) ยท Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) ยท Last updated: May 2026 ยท Source: Indian Customs (DGFT) Records
HS Code 30024129 (Vaccines for human medicine (COVID-19 etc.)) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $174.6B across 1,320 shipments, this code covers 4 distinct pharmaceutical products exported by 18 Indian manufacturers to 35 countries. The leading product under this classification is Vaccine at $174.6B, followed by Liraglutide and Probiotics.
The top importing markets include Pakistan, Nigeria, Bangladesh. The top 5 products account for 100.0% of total trade under this code. Average transaction value is $132.3M. Leading exporters include GLAXOSMITHKLINE BIOLOGICALS SA and SANOFI PASTEUR. Data sourced from Indian Customs (DGFT) shipping bill records.

Products Exported Under HS Code 30024129
4 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Vaccine | $174.6B | 1,315 | $2292.54 | 71 |
| #2 | Liraglutide | $5.0K | 2 | $12.60 | 1 |
| #3 | Probiotics | $3.2K | 1 | $248.66 | 1 |
| #4 |